Potential impact of 5 years of ivermectin mass drug administration on malaria outcomes in high burden countries

• Regina Rabinovich,
• Carlos J Chaccour,
• Achla Marathe,
• Bryan Lewis,
• Ruoding Shi,
• Ana Mendez-Lopez,
• Zhihao Hu,
• Cassidy Rist

Affiliations

Regina Rabinovich

Malaria Elimination Initiative, Barcelona Institute for Global Health, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalunya, Spain

Carlos J Chaccour

7Instituto de Salud Global, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain

Achla Marathe

Network Dynamics and Simulation Sciences Laboratory, Biocomplexity Institute, Virginia Tech, Blacksburg, Virginia, USA

Bryan Lewis

Network Dynamics and Simulation Sciences Laboratory, Biocomplexity Institute, Virginia Tech, Blacksburg, Virginia, USA

Ruoding Shi

2 Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA

Ana Mendez-Lopez

3 Department of Preventive Medicine, Public Health and Microbiology, Autonomous University of Madrid, Madrid, Spain

Zhihao Hu

5 Department of Statistics, Virginia Tech, Blacksburg, Virginia, USA

Cassidy Rist

7 Department of Population Health Sciences, Virginia Tech, Blacksburg, Virginia, USA